U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07096258) titled 'EMPATHY NSCLC: European Registry for Plasma-Based Molecular Profiling in Advanced NSCLC Patients' on July 24.
Brief Summary: The goal of this registry is to capture real-world data from plasma- and tissue-based molecular profiling, treatments, outcomes and patient-reported outcomes from patients with advanced or metastatic non-small cell lung cancer (NSCLC). The main objective of the study is to better understand the real-world clinical practice of the use and utility of molecular tumour profiling, the choice of treatment, and the outcome after such molecular profiling and treatment.
Study Start Date: June 01, 2024
Study Type: OBSE...